Kentucky Rescinds Dextrophan Positives: Blood-Horse 2/21/17

By: Frank Angst Citing new research that suggests the metabolite of Dextromethorphan, Dextrorphan, can stay in a horse's system at a wider variance of time than previously realized, the Kentucky Horse Racing Commission earlier this year dropped sanctions in three cases where the metabolite was discovered. KHRC equine medical director Mary Scollay offered a presentation

Maker has 40-Day Suspension Rescinded: Daily Racing Form 1/6/17

By: Matt Hegarty LEXINGTON, Ky. – Stewards in Kentucky have issued a ruling rescinding a 40-day suspension handed down last year to trainer Mike Maker for a post-race positive of dextrorphan, the metabolite of a once-common ingredient in cough syrup, according to a copy of the ruling and racing officials. The ruling, issued on Thursday,

Studies on Lasix Administration Progressing:Blood-Horse 3/23/16

By: Frank Angst In a presentation at the Association of Racing Commissioners International conference March 23 in New Orleans, Jockey Club executive director Matt Iuliano highlighted studies examining the efficacy of administering furosemide at least 24 hours before a race. RCI president Ed Martin noted that some conference presentations will allow member commissioners to see

Foundation Authorizes Two Lasix Studies: The Blood-Horse 9/15/15

By Blood-Horse Staff Two research projects designed to study the impact of furosemide on exercise-induced pulmonary hemorrhage will be conducted on behalf of the Grayson-Jockey Club Research Foundation, the organization said Sept. 15. The studies will examine the pathophysiology of EIPH, or bleeding in horses' lungs. The condition is currently treated with furosemide, also known

RMTC Makes Therapeutic Withdrawal Time Recommendations, Announces Progress of its Drug… 10/20/10

NEWS RELEASE October 20, 2010 Contact: Hallie Lewis (859) 224-2848 RMTC MAKES THERAPEUTIC WITHDRAWAL TIME RECOMMENDATIONS, ANNOUNCES PROGRESS OF ITS DRUG TESTING INITIATIVES TASK FORCE Based on the recommendation of its Scientific Advisory Committee, the Racing Medication and Testing Consortium (RMTC) board of directors has recommended scientifically identified withdrawal guidelines and plasma thresholds for the

RMTC Board Will Meet Next Week in Austin, Texas 3/20/08

NEWS RELEASE March 20, 2008 RMTC BOARD WILL MEET NEXT WEEK IN AUSTIN, TEXAS On Tuesday, March 25, the board of directors of the Racing Medication and Testing Consortium (RMTC) will meet at the Driskell Hotel in Austin, Texas, for their spring board meeting. The RMTC will hear reports from four of its committees, including